Mindbloom Named One of the 50 Best Remote-First Companies to Work For

Medically reviewed by

Published on

January 11, 2021

Updated on

January 27, 2022

In 2021, Mindbloom was recognized by Built In as one of the "50 Best Remote-First Companies to Work For in 2021."

Mindbloom was joined by remote-first tech giants Twitter, Dropbox, and Slack, and along with Hims/Hers is one of few healthcare brands recognized by Built In in the remote-first category.

“Built In’s editorial teams have hand-selected the 50 Best Remote-First Companies to Work For. All have made long-term commitments to hiring and supporting remote employees, and we think they have the perks, culture and organizational capacity to allow all workers’ careers to flourish, regardless of location,” Built In mentions in their announcement.

Mindbloom has been a remote-first company since its inception in 2019. After piloting clinical services with a physical clinic in NYC, Mindbloom quickly adapted to the impact of COVID-19 in 2020 by offering clients fully virtual, at-home psychedelic therapy.

“Being a remote-first company, both as an employer and as a client-facing service, helps us increase access to psychedelic therapy for people who otherwise wouldn't be able to obtain it. The cherry on top is working with a phenomenal group of people around the world who are super mission-driven to transform people's lives and transform the world,” Georgette Monserrat, People Lead at Mindbloom, says, “I'm psyched to be part of such a progressive, trail-blazing company working in the cutting edge field of psychedelic telemedicine.”

If you’re interested in joining Mindbloom, a leader in remote-first psychedelic medicine and healthcare, check our Careers page for opportunities.

Learn more about Mindbloom’s mission, and how Mindbloom’s psychedelic therapy program works.

Mindbloom Editorial Team

Mindbloom is a leader in psychedelic therapy, transforming lives to transform the world. Our editorial team shares the latest Mindbloom news, and collaborates with Mindbloom clients to help share their stories with the world.

This article is for informational purposes only and is not intended to be a substitute for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment. If you are in a life-threatening situation, call the National Suicide Prevention Line at +1 (800) 273-8255, call 911, or go to the nearest emergency room.

Safety Information

Important FDA Safety Information

Ketamine is not FDA-approved for the treatment of depression or anxiety. Learn more about off-label uses here.

Side effects of ketamine treatment may include: altered sense of time, anxiety, blurred vision, diminished ability to see/hear/feel, dry mouth, elevated blood pressure or heart rate, elevated intraocular or intracranial pressure, excitability, loss of appetite, mental confusion, nausea/vomiting, nystagmus (rapid eye movements), restlessness, slurred speech, synesthesia (a mingling of the senses).

Do not proceed with ketamine treatment if any of the following apply to you:

Allergic to ketamine
Symptoms of psychosis or mania
Uncontrolled high blood pressure
CHF or other serious heart problem
Severe breathing problem
History of elevated intraocular or intracranial pressure
History of hyperthyroidism
Other serious medical illness
Pregnant, nursing, or trying to become pregnant

Ketamine has been reported to produce issues including, but not limited to, those listed below. However, lasting adverse side-effects are rare when medical protocols are carefully followed.

While ketamine has not been shown to be physically addictive, it has been shown to cause moderate psychological dependency in some recreational users.

In rare cases, frequent, heavy users have reported increased frequency of urination, urinary incontinence, pain urinating, passing blood in the urine, or reduced bladder size
Ketamine may worsen problems in people with schizophrenia, severe personality disorders, or other serious mental disorders.
Users with a personal or family history of psychosis should be cautious using any psychoactive substance, including ketamine, and discuss potential risks with your MindBloom^® clinician before proceeding with treatment.
The dissociative effects of ketamine may increase patient vulnerability and the risk of accidents.

To promote positive outcomes and ensure safety, follow these ketamine treatment guidelines:

Do not operate a vehicle (e.g., car, motorcycle, bicycle) or heavy machinery following treatment until you’ve had a full night of sleep
Refrain from taking benzodiazepines or stimulants for 24 hours prior to treatment
Continue to take antihypertensive medication as prescribed
Avoid hangovers or alcohol intake
Refrain from consuming solid foods within 3 hours prior to treatment and liquids within 1 hour prior to treatment
Ketamine treatment should never be conducted without a monitor present to ensure your safety